关注
zuoxu xie
标题
引用次数
引用次数
年份
Long noncoding RNA (lncRNA)-mediated competing endogenous RNA networks provide novel potential biomarkers and therapeutic targets for colorectal cancer
L Wang, KB Cho, Y Li, G Tao, Z Xie, B Guo
International journal of molecular sciences 20 (22), 5758, 2019
4022019
Retro-inverso CendR peptide-mediated polyethyleneimine for intracranial glioblastoma-targeting gene therapy
J Wang, Y Lei, C Xie, W Lu, E Wagner, Z Xie, J Gao, X Zhang, Z Yan, ...
Bioconjugate chemistry 25 (2), 414-423, 2014
582014
Targeted gene delivery to glioblastoma using a C-end rule RGERPPR peptide-functionalised polyethylenimine complex
J Wang, Y Lei, C Xie, W Lu, Z Yan, J Gao, Z Xie, X Zhang, M Liu
International journal of pharmaceutics 458 (1), 48-56, 2013
572013
D‐peptides as recognition molecules and therapeutic agents
M Liu, X Li, Z Xie, C Xie, C Zhan, X Hu, Q Shen, X Wei, B Su, J Wang, ...
The Chemical Record 16 (4), 1772-1786, 2016
522016
Nitric oxide (NO) and NO synthases (NOS)-based targeted therapy for colon cancer
H Wang, L Wang, Z Xie, S Zhou, Y Li, Y Zhou, M Sun
Cancers 12 (7), 1881, 2020
432020
Retro-inverso bradykinin opens the door of blood–brain tumor barrier for nanocarriers in glioma treatment
Z Xie, Q Shen, C Xie, W Lu, C Peng, X Wei, X Li, B Su, C Gao, M Liu
Cancer Letters 369 (1), 144-151, 2015
302015
D-SP5 peptide-modified highly branched polyethylenimine for gene therapy of gastric adenocarcinoma
X Li, Z Xie, C Xie, W Lu, C Gao, H Ren, M Ying, X Wei, J Gao, B Su, Y Ren, ...
Bioconjugate Chemistry 26 (8), 1494-1503, 2015
282015
Effect of Retro‐Inverso Isomer of Bradykinin on Size‐Dependent Penetration of Blood–Brain Tumor Barrier
B Su, R Wang, Z Xie, H Ruan, J Li, C Xie, W Lu, J Wang, D Wang, M Liu
Small 14 (7), 1702331, 2018
242018
MPEG-DSPE polymeric micelle for translymphatic chemotherapy of lymph node metastasis
X Li, Q Dong, Z Yan, W Lu, L Feng, C Xie, Z Xie, B Su, M Liu
International Journal of Pharmaceutics 487 (1-2), 8-16, 2015
172015
ACQ-to-AIE conversion by regio-isomerization of rofecoxib analogues for developing new multi-functional aggregation-induced emission luminogens
X Wang, W Liu, X Lin, L Chen, Z Wang, Z Xie, L Wang, M Hu, H Jiang, ...
Dyes and Pigments 198, 109992, 2022
122022
Isomeric folate-conjugated polymeric micelles bind to folate receptors and display anticancer effects
Q Dong, ZX Xie, C Xie, WY Lu, Q Zhang, X Li, M Liu
Asian Pacific Journal of Cancer Prevention 15 (17), 7363-7369, 2014
102014
One-step transformation from rofecoxib to a COX-2 NIR probe for human cancer tissue/organoid targeted bioimaging
L Xie, R Li, B Zheng, Z Xie, X Fang, T Dai, X Wang, L Li, L Wang, ...
ACS Applied Bio Materials 4 (3), 2723-2731, 2021
92021
Development of rofecoxib-based fluorescent probes and investigations on their solvatochromism, AIE activity, mechanochromism, and COX-2-targeted bioimaging
L Xie, R Li, B Zheng, Z Xie, X Fang, Y Wang, GD Cuny, Z Li, B Lin, X Chen, ...
Analytical chemistry 93 (35), 11991-12000, 2021
82021
Design and synthesis of a novel nir celecoxib-based fluorescent probe for cyclooxygenase-2 targeted bioimaging in tumor cells
X Wang, L Wang, L Xie, Z Xie, L Li, D Bui, T Yin, S Gao, M Hu
Molecules 25 (18), 4037, 2020
82020
Development of Rofecoxib‐Based Fluorophores from ACQ to AIE by Positional Regioisomerization
X Wang, L Chen, R Li, Z Xie, M Hu, S Sun, Z Li, J Hao, B Lin, X Chen, ...
ChemPlusChem 87 (4), e202100522, 2022
32022
Knowledge mapping concerning applications of nanocomposite hydrogels for drug delivery: A bibliometric and visualized study (2003–2022)
H Wang, H Fu, Y Fu, L Jiang, L Wang, H Tong, Z Xie, P Huang, M Sun
Frontiers in Bioengineering and Biotechnology 10, 1099616, 2023
22023
Comparison of Absolute Expression and Turnover Number of COX-1 and COX-2 in Human and Rodent Cells and Tissues
L Li, R Sun, J Zenga, H Himburg, L Wang, S Duan, J Liu, D Bui, Z Xie, ...
Journal of Inflammation Research, 4435-4447, 2022
12022
Reduction of Systemic Exposure and Side Effects by Intra-articular Injection of Anti-inflammatory Agent for Osteoarthritis: What is the Safer Strategy?
Z Xie, L Wang, J Chen, Z Zheng, S Srinual, A Guo, R Sun, M Hu
Journal of Drug Targeting, 1-30, 2023
2023
Development of Rofecoxib-Based Fluorescent Probes and Investigations on Their AIE Activity, Solvatochromism, Mechanochromism and COX-2 Targeted Bioimaging
L Xie, R Li, B Zheng, Z Xie, X Fang, Y Wang, G Cuny, Z Li, B Lin, X Chen, ...
2021
系统目前无法执行此操作,请稍后再试。
文章 1–19